PRLD Initiates PRT12396 Phase 1 Study, $90M Offering Extends Cash Runway into Q2 2028
Prelude Therapeutics Incorporated · PHARMACEUTICAL PREPARATIONS · Now $3.82
-6.7% in 7d after detection
Post-detection moves
1h
—
1d
+0.4%
3d
-3.4%
7d
-6.7%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS